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 ABSTRACT
General distress, shared across depression, anxiety and 
anger, partly accounts for the link between mind and 
heart. The type D (distressed) personality profi le identi-
fi es individuals who are particularly vulnerable to the 
adverse effect of general distress. Type D individuals 
frequently experience negative emotions and are socially 
inhibited. This profi le is more stable than that associated 
with episodes of clinical depression and describes the 
chronic nature of distress in some patients. Type D may 
also partly account for the effect of emotional distress on 
cardiac prognosis. Type D is associated with a threefold 
increased risk of adverse cardiovascular outcomes, even 
after adjustment for depression. This relationship is less 
obvious in patients with heart failure. Plausible pathways 
linking type D to cardiovascular complications include 
hypothalamic-pituitary-adrenal–axis hyperreactivity, 
autonomic and infl ammatory dysregulation, and increased 
oxidative stress. Research needs to further clarify these 
pathways and investigate whether type D patients may 
benefi t from closer monitoring of risk factors and a per-
sonalized approach to behavioral intervention. The DS14 
is a brief, well-validated measure of type D that could be 
incorporated into clinical research and practice to identify 
high-risk patients. 
Depression has been studied extensively in relation to cardiovascular disease.1–3 In addi-tion to depression, anger4 and anxiety5 also may promote coronary artery disease (CAD), 
suggesting that emotional distress in general may be 
related to increased cardiovascular risk. Evidence indi-
cates that the general distress shared across depression, 
anger, and anxiety predicts CAD, even after control-
ling for each of these specifi c negative emotions.6
 THE CONCEPT OF TYPE D PERSONALITY 
Lately, there is a renewed interest in broad individual 
differences in general distress and heart disease.7 
Since psychologic factors often cluster together in 
individual patients, biobehavioral research may ben-
efi t from the identifi cation of discrete personality sub-
types.8 This focus on the identifi cation of psychologi-
cally vulnerable patients who are at increased risk for 
adverse outcomes has led to the introduction of the 
distressed9 or type D10 personality profi le in cardiovas-
cular research. This personality construct is defi ned 
as follows: 
“The type D (distressed) personality profi le refers to 
a general propensity to psychological distress that is char-
acterized by the combination of negative affectivity and 
social inhibition.”10
Negative affectivity, or the tendency to experi-
ence negative emotions across time and situations, 
is a major determinant of emotional distress in car-
diac patients.9,10 Patients who score high on this trait 
frequently report feelings of dysphoria, worry, and 
tension. Social inhibition, or the tendency to inhibit 
the expression of emotions or behavior, is a major 
determinant of social distress.9,10 Patients who score 
high on this trait tend to avoid negative reactions 
from others. 
Both traits defi ne psychologically vulnerable 
patients and can be assessed with the type D scale 
(DS14).10 This brief measure consists of a seven-item 
negative affectivity subscale (eg, I often feel unhappy) 
and a seven-item inhibition subscale (eg, I am inhib-
ited in social interactions), and has a clear two-factor 
structure and good reliability (Cronbach’s  = .88 and 
.86). Patients are classifi ed as type D if they score 10 
or higher on both DS14 subscales.10 The prevalence 
of type D personality ranges between 20% and 40% 
across different types of cardiovascular conditions. 
The type D construct was designed for the early 
identifi cation of chronically distressed patients. This 
article reviews (1) the risk of adverse events associ-
ated with type D, (2) the extent to which type D is 
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distinct from depression, (3) the biologic pathways of 
type D, and (4) the implications of the type D per-
sonality profi le. 
 RISK ASSOCIATED WITH TYPE D
Several prospective studies from our group have exam-
ined the notion that type D patients are particularly 
vulnerable to adverse events (Table 1). In patients 
with CAD, evidence indicates that type D personality 
is an independent predictor of adverse events, includ-
ing (cardiac) death, myocardial infarction, and need 
for revascularization procedures.11–16 In these studies, 
type D also emerged as an independent predictor of 
adverse events after adjustment for anxiety,11 stress,13 
depression,16 disease severity,11–16 and type of invasive 
treatment.14 This increased risk associated with the 
type D profi le was observed in the broader group of 
patients with CAD,11–15 as well as in patients who 
survived an initial myocardial infarction.16
The relationship between type D personality and 
adverse events has also been investigated in other 
cardiovascular conditions. Type D has been associated 
with poor prognosis in patients with peripheral arterial 
disease,17 but evidence for the prognostic role of type 
D in patients with chronic heart failure is mixed. In a 
study of patients with heart failure following myocar-
dial infarction, type D predicted cardiac death inde-
pendent of disease severity18; in a study of heart failure 
patients who underwent cardiac transplantation, 
type D was associated with early allograft rejection 
and increased mortality.19 However, type D was not 
associated with cardiac death in a recent, larger heart 
failure study.20 The link between psychologic factors 
and heart failure is complex3 and may be less obvious 
than the type D-CAD link.20 Type D has also been 
associated with the occurrence of life-threatening 
arrhythmias following implantable cardioverter defi -
brillator (ICD) treatment,21 and it has been shown to 
predict an increased risk for mortality in ICD patients, 
independent from shocks and disease severity.22
The wide range in odds ratios and confi dence 
intervals indicates disparity in data across these type 
D studies (Table 1). We recently performed a meta-
analysis of prospective studies between 1996 and 2009 
to provide a more reliable estimate of the risk associ-
ated with type D. In this analysis, type D was associated 
with a threefold increased risk of adverse events23; the 
confi dence interval of this pooled odds ratio ranged 
TABLE 1
Type D and risk of clinical events in cardiovascular disease patients
Cardiovascular
disease (n) Clinical event (follow-up) OR/HR (95% CI) Meta-analytic review23
CAD
CAD (303)11 Total mortality (6–10 y) OR = 4.1 (1.9–8.8)* Included in meta-analysis
CAD (319)12 Cardiac death, MI (5 y) OR = 8.9 (3.2–24.7)† Included in meta-analysis
CAD (337)13 Total mortality, MI (5 y) OR = 4.8 (1.4–16.5)* Included in meta-analysis
CAD (875)14 Total mortality, MI (9 mo) OR = 5.3 (2.0–13.6)† Included in meta-analysis
CAD (358)15 Total mortality, MI (2 y) HR = 2.6 (1.1–6.0)‡ Included in meta-analysis
CAD (473)16 Cardiac death, MI (1.8 y) HR = 2.2 (1.1–4.3)‡ Not included in meta-analysis
Other
PAD (184)17 Total mortality (4 y) HR = 3.5 (1.1–11.1)‡ Included in meta-analysis
CHF (87)18 Cardiac death, MI (6–10 y) OR = 4.7 (1.9–11.8)* Included in meta-analysis
CHF/HT (51)19  Mortality, rejection (5.4 y) OR = 6.8 (1.4–30.9)‡ Included in meta-analysis
CHF (641)20 Cardiac death (3.1 y) HR = 1.2 (0.6–2.1) Not included in meta-analysis
ICD (391)21 Ventricular arrhythmia (1 y) HR = 1.9 (1.1–3.1)‡ Not included in meta-analysis
ICD (371)22 Total mortality (1.7 y) HR = 2.8 (1.2–6.2)* Not included in meta-analysis
* P < .01; † P < .0001; ‡ P < .05 
CAD = coronary artery disease; CHF = chronic heart failure; HR = hazard ratio; HT= heart transplantation; ICD = implantable cardioverter defi brillator; MI = myocardial infarction; 
OR = odds ratio; PAD = peripheral arterial disease
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from 2.7 to 5.1. In addition, type D personality was 
associated with a threefold increased risk (range, 2.6 to 
4.3) of emotional distress over time.23 From the recent 
studies that were not included in this meta-analysis, 
one reported negative fi ndings20 and three others posi-
tive fi ndings16,21,22 on the risk associated with type D.
 COMPARING DEPRESSION AND TYPE D
Many studies report on depression and cardiac dis-
ease,1–3 but both conceptual differences and clinical 
evidence indicate that type D and depression are dis-
tinct forms of distress (Table 2). Conceptually, type 
D focuses not only on depressive affect but also on 
the general distress shared across negative emotions,10 
and it is based on the notion that social inhibition 
modulates the effect of negative emotions on cardiac 
prognosis.24 While depression refers to an episodic 
distress factor (patients may go in and out of depres-
sive episodes), the type D construct focuses on an 
underlying factor that predisposes patients to more 
chronic forms of distress.8
Clinical evidence shows that, after adjustment for 
depression, type D remained a predictor of adverse 
cardiac events in CAD.16,24,25 Following ICD implan-
tation, anxious type D patients were at risk of ventric-
ular arrhythmias, whereas depression did not predict 
arrhythmias.21 Type D also exerts an adverse effect 
on patients’ health status following coronary bypass 
surgery,26 heart failure,27 or myocardial infarction,28 
adjusting for depressive symptoms. Type D is related 
to biomarkers of increased stress levels independent 
of depression29–31 and, unlike depression,  type D is 
not confounded by the severity of cardiac disorder.32
Following myocardial infarction, only one of four 
distressed patients met criteria for both type D and 
depression; most had one form of distress but not the 
other.32 Research in healthy33 and in cardiac34 popula-
tions confi rmed that items from depression and type 
D scales refl ect different distress factors. After adjust-
ment for depression at baseline, type D also predicted 
the incidence,35 persistence,36 and severity37,38 of 
depression and anxiety. However, these fi ndings do 
not imply that depression and type D are antonymous 
perspectives or that one perspective is better than the 
other in predicting outcomes; rather, we would like to 
argue that both constructs represent complementary 
perspectives that have added value.23
 BIOLOGIC PATHWAYS OF TYPE D
A number of biologic pathways have been suggested 
to explain the effect of type D (Table 3). Some 
have suggested dysregulation of the hypothalamic-
pituitary-adrenal axis in patients with type D person-
ality.39 In fact, type D has been associated with greater 
cortisol reactivity to stress in healthy individuals40 
and with higher awakening30 and daytime31 cortisol 
levels in CAD patients. Autonomic dysregulation 
can also be inferred in type D individuals on the 
basis of a higher resting heart rate41 and cardiovas-
cular hyperreactivity40,42 and decreased heart rate 
variability43 in response to stress. In addition, type D 
has been related to reduced heart rate recovery after 
TABLE 2
Type D and depression are different forms of 
distress in cardiovascular disease patients
 Conceptual differences
Emotional  Type D focuses on general distress shared 
 across negative emotions (anxiety, irritability, 
 and others10) in addition to depressive affect
Social Social inhibition is a factor in type D that
 may moderate the expression of emotions
 and behaviors in social interaction24
Duration  Emotional and social distress is a chronic 
 factor (≥ 2 years) in type D, whereas it is an 
 episodic factor (< 2 years) in depression 8–10
 Cardiovascular outcomes 
Clinical  Type D personality predicts mortality and 
events  other clinical events in cardiac patients,
 even after adjustment for severity16 and 
 symptoms24,25 of depression
Health Type D personality independently predicts 
status poor health status over time in cardiac
 patients, above and beyond symptoms of 
 depression26–28
Pathways  Type D personality predicts increased oxida-
of disease tive stress and cortisol levels in cardiac
 patients after adjustment for depressive 
 symptoms29–31
 Psychologic outcomes 
Distinct There is only limited overlap between type D
diagnosis  and depression classifi cation25,32; items in
 type D and depression scales refl ect different 
 distress factors
Depressive  Type D personality predicts the onset and 
symptoms persistence of depressive symptoms in 
 cardiac patients, controlling for depression at
 baseline35,36
Anxiety  Type D personality predicts the occurrence 
symptoms and severity of anxiety in cardiac patients, 
 above and beyond symptoms of depression37,38
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exercise in patients with heart failure.44 These indices 
of excessive sympathetic or inadequate parasympa-
thetic modulation of heart rate predict poor cardiac 
prognoses.45
Other studies found that type D was associated 
with infl ammatory dysregulation. In healthy adults, 
type D has been related to higher concentrations of 
C-reactive protein.41 In heart failure patients, type D 
is associated with increased plasma levels of the pro-
infl ammatory cytokine tumor necrosis factor (TNF)- 
and its soluble receptors 1 and 2.46,47 Increased TNF- 
levels may cause suppression of bone-marrow–derived 
endothelial progenitor cells (EPCs) that play an 
important role in maintaining vascular integrity. The 
negative affectivity component of type D has been 
shown to predict decreased circulating EPC counts in 
healthy individuals48; another study found that these 
EPC numbers were reduced by more than 50% in 
heart failure patients with a type D personality.49 Type 
D personality is also associated with an increased oxi-
dative stress burden in patients with chronic heart 
failure.29 Studies on genetic linkage50 and heritability51 
further support biologic underpinnings of the type D 
construct. 
Regarding pathways that may explain the effect 
of type D, some issues are of special interest. First, 
genetic factors contribute to stability in type D 
personality, but environmental factors may induce 
changes in type D characteristics over time.51 Hence, 
given this role of environmental infl uences over time, 
behavioral intervention would be feasible and useful 
in type D patients. Second, type D can promote heart 
disease indirectly through behavioral pathways. Type 
D has been associated with a sedentary lifestyle,41,52 
an unhealthy diet,53 and a passive coping style.54,55 
Poor adherence to medical treatment56,57 and reluc-
tance to consult clinical staff58 may jeopardize the 
working relationship with type D patients in clinical 
care. Intervention may focus on the management of 
these behavioral risk factors in type D patients. Third, 
many of these biologic40–43,48,50,51 and behavioral41,52–54 
pathways have also been documented in healthy type 
D individuals, which suggests that these associations 
cannot be explained away by the confounding effect 
of underlying cardiovascular disease. 
 CLINICAL IMPLICATIONS OF TYPE D 
The fi ndings from type D research have a number 
of clinical implications. Type D is associated with 
an increased risk of adverse events,23 chronic dis-
tress,35–38 and suicidal ideation.59 Type D may also 
have an adverse effect on the outcome of invasive 
treatment.14,19,21,22,24,26,60
Type D was associated with mortality and morbid-
ity at 9 months14 and 2 years24 following coronary 
artery stenting, and with impaired health status 1 
year following bypass surgery.26 Type D also predicted 
mortality and allograft rejection following heart 
transplantation,19 and an increased risk of ventricu-
lar arrhythmia21 and mortality22 in ICD patients. 
Researchers from the Cleveland Clinic have shown 
that type D is a risk factor for anxiety in ICD patients.60
Regarding the DSM-IV classifi cation by the 
American Psychiatric Association,61 type D quali-
fi es for the diagnosis “psychological factors affecting 
medical condition” (Section 316). In keeping with 
this classifi cation, the diagnostic category type D 
affects (1) the course of cardiovascular conditions,23 
(2) the treatment of these conditions,56,57 and (3) the 
working relationship with medical staff.58 At present, 
no clinical trial has examined whether intervention 
for distress among type D patients alters their risk for 
adverse events. Nevertheless, some have argued that 
it is plausible for type D patients to learn new strate-
gies to reduce their level of general distress.62 Previous 
research with patients experiencing symptoms like 
those of type D patients suggests that psychotherapy, 
TABLE 3
Potential biologic mechanisms underlying type D
 Healthy Cardiovascular  
 individuals patients
HPA-axis  Increased cortisol Higher CAR30;
dysregulation  reactivity to stress40 higher daytime 
  cortisol31
Autonomic Higher HR41; increased Reduced HR
dysregulation  CV stress reactivity40,42; recovery after
 decreased HRV43 exercise44
Infl ammatory  Higher concentration Increased plasma 
dysregulation of CRP41 levels of TNF-, 
  TNFR1, TNFR246,47
Reduced  Decreased EPC counts Decreased EPC
number of associated with NA48 counts associated 
stem cells  with type D49
Increased   Lower levels of
oxidative   Hsp70 and higher 
stress  levels of XO29
CAR = cortisol awakening response; CRP = C-reactive protein; CV = cardio-
vascular; EPC = bone marrow-derived endothelial progenitor cells; HPA = 
hypothalamic-pituitary-adrenal; HR = heart rate; HRV = heart rate variability; 
Hsp70 = heat shock protein 70; NA = negative affectivity; TNF- = tumor necrosis 
factor-; TNFR1 = soluble TNF- receptor 1; TNFR2 = soluble TNF- receptor 2; 
XO = xanthine oxidase
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social skills training, stress management, and relax-
ation training may reduce stress in these patients and 
improve their ability to express their emotions to 
others.62 Others have suggested that stress manage-
ment training, including communication skills and 
problem-solving, may further improve the risk profi le 
and health in cardiac patients.63
It is possible that type D patients may benefi t from 
close monitoring of their clinical condition and from 
aggressive management of their risk factor profi le to 
prevent adverse clinical events. Cardiac rehabilita-
tion is an effective approach to treating risk factors 
and enhancing well-being in CAD.63,64 A few studies 
have examined the effect of cardiac rehabilitation 
in type D patients. One study found a signifi cant 
decrease in the social inhibition component of type 
D following cardiac rehabilitation, but there was no 
change in the prevalence of type D at 1-year follow-
up.65 Although the type D profi le tends to remain 
stable during rehabilitation,65,66 evidence shows that 
type D patients who participate in cardiac rehabilita-
tion improve in physical and mental health status.66 
Cardiac rehabilitation may also ward off further 
deterioration in negative affect,67 which, in turn, has 
been associated with better survival in patients who 
participated in rehabilitation.68 Future studies need 
to examine the effect of cardiac rehabilitation and 
other personalized approaches to treatment in type D 
patients.
 CONCLUSIONS
General distress shared across negative emotions6,23 
may partly account for the role of depression, anxiety, 
and anger in cardiovascular disorders.1–5 Some cardiac 
patients are more likely to experience distress than 
others. Type D may identify these psychologically 
vulnerable patients who tend to experience general 
distress.23 This propensity to general distress differs 
from depression, predicts adverse outcomes, is linked 
to plausible biologic pathways, and highlights the 
chronic nature of psychologic distress in some cardiac 
patients. 
After adjustment for depression, type D remains 
signifi cantly associated with an increased risk of 
adverse events in patients with CAD.16,24,25 However, 
this association is less obvious in patients with heart 
failure, and type D did not predict survival in one 
heart failure study.20 Although initial fi ndings suggest 
a number of plausible biologic and behavioral path-
ways, more research is needed to explain the adverse 
effect of type D on cardiovascular outcomes. Future 
research also needs to investigate whether type D 
patients may benefi t from close monitoring of their 
risk factors and a more personalized approach to 
behavioral and cardiac treatment. 
Overall, the current understanding of type D indi-
cates that general distress should not be ignored in the 
link between mind and heart, and that cardiovascular 
patients who have a type D personality profi le are par-
ticularly vulnerable to the adverse clinical effects of 
general distress. The DS1410 is a brief, well-validated 
measure of type D that could be incorporated into 
clinical research and practice to identify patients who 
are at risk of chronic distress and poor prognosis. 
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 21. van den Broek KC, Nyklíček I, van der Voort PH, Alings M, 
Meijer A, Denollet J. Risk of ventricular arrhythmia after implant-
able defi brillator treatment in anxious type D patients. J Am Coll 
Cardiol 2009; 54:531–537.
 22. Pedersen SS, van den Broek KC, Erdman RA, Jordaens L, 
Theuns DA. Pre-implantation implantable cardioverter defi brilla-
tor concerns and Type D personality increase the risk of mortality 
in patients with an implantable cardioverter defi brillator. Europace 
2010; 12:1446–1452. 
 23. Denollet J, Schiffer AA, Spek V. A general propensity to psy-
chological distress affects cardiovascular outcomes: evidence from 
research on the type D (distressed) personality profi le. Circ Cardio-
vasc Qual Outcomes 2010; 3:546–557.
 24. Denollet J, Pedersen SS, Ong AT, Erdman RA, Serruys PW, van 
Domburg RT. Social inhibition modulates the effect of negative 
emotions on cardiac prognosis following percutaneous coronary 
intervention in the drug-eluting stent era. Eur Heart J 2006; 
27:171–177.
 25. Denollet J, Pedersen SS. Prognostic value of Type D personal-
ity compared with depressive symptoms. Arch Intern Med 2008; 
168:431–432.
 26. Al-Ruzzeh S, Athanasiou T, Mangoush O, et al. Predictors of poor 
mid-term health related quality of life after primary isolated coro-
nary artery bypass grafting surgery. Heart 2005; 91:1557–1562.
 27. Schiffer AA, Pedersen SS, Widdershoven JW, Denollet J. Type 
D personality and depressive symptoms are independent predictors 
of impaired health status in chronic heart failure. Eur J Heart Fail 
2008; 10:802–810.
 28. Mols F, Martens EJ, Denollet J. Type D personality and depressive 
symptoms are independent predictors of impaired health status fol-
lowing acute myocardial infarction. Heart 2010; 96:30–35.
 29. Kupper N, Gidron Y, Winter J, Denollet J. Association between 
type D personality, depression, and oxidative stress in patients with 
chronic heart failure. Psychosom Med 2009; 71:973–980.
 30. Whitehead DL, Perkins-Porras L, Strike PC, Magid K, Step-
toe A. Cortisol awakening response is elevated in acute coronary 
syndrome patients with type-D personality. J Psychosom Res 2007; 
62:419–425. 
 31. Molloy GJ, Perkins-Porras L, Strike PC, Steptoe A. Type-D 
personality and cortisol in survivors of acute coronary syndrome. 
Psychosom Med 2008; 70:863–868.
 32. Denollet J, de Jonge P, Kuyper A, et al. Depression and Type D 
personality represent different forms of distress in the Myocardial 
INfarction and Depression–Intervention Trial (MIND-IT). Psychol 
Med 2009; 39:749–756. 
 33. Kudielka BM, von Känel R, Gander ML, Fischer JE. The inter-
relationship of psychosocial risk factors for coronary artery disease 
in a working population: do we measure distinct or overlapping 
psychological concepts? Behav Med 2004; 30:35–43.
 34. Pelle AJ, Denollet J, Zwisler AD, Pedersen SS. Overlap and dis-
tinctiveness of psychological risk factors in patients with ischemic 
heart disease and chronic heart failure: are we there yet? J Affect 
Disord 2009; 113:150–156.
 35. Pedersen SS, Ong AT, Sonnenschein K, Serruys PW, Erdman 
RA, van Domburg RT. Type D personality and diabetes predict 
the onset of depressive symptoms in patients after percutaneous 
coronary intervention. Am Heart J 2006; 151:367.e1–367.e6.
 36. Martens EJ, Smith OR, Winter J, Denollet J, Pedersen SS. 
Cardiac history, prior depression and personality predict course 
of depressive symptoms after myocardial infarction. Psychol Med 
2008; 38:257–264.
 37. van Gestel YR, Pedersen SS, van de Sande M, et al. Type-D 
personality and depressive symptoms predict anxiety 12 months 
post-percutaneous coronary intervention. J Affect Disord 2007; 
103:197–203.
 38. Schiffer AA, Pedersen SS, Broers H, Widdershoven JW, Denol-
let J. Type-D personality but not depression predicts severity of 
anxiety in heart failure patients at 1-year follow-up. J Affect Disord 
2008; 106:73–81.
 39. Sher L. Type D personality: the heart, stress, and cortisol. QJM 
2005; 98:323–329. 
 40. Habra ME, Linden W, Anderson JC, Weinberg J. Type D person-
ality is related to cardiovascular and neuroendocrine reactivity to 
acute stress. J Psychosom Res 2003; 55:235–245. 
 41. Einvik G, Dammen T, Hrubos-Strøm H, et al. Prevalence of cardio-
vascular risk factors and concentration of C-reactive protein in type 
D personality persons without cardiovascular disease [published online 
ahead of print February 9, 2011]. Eur J Cardiovasc Prev Rehabil. 
PMID: 21450648. 
 42. Williams L, O’Carroll RE, O’Connor RC. Type D personality 
and cardiac output in response to stress. Psychol Health 2009; 
24:489–500. 
 43. Martin LA, Doster JA, Critelli JW, et al. Ethnicity and Type D 
personality as predictors of heart rate variability. Int J Psychophysiol 
2010; 76:118–121. 
 44. von Känel R, Barth J, Kohls S, et al. Heart rate recovery after 
exercise in chronic heart failure: role of vital exhaustion and type D 
personality. J Cardiol 2009; 53:248–256. 
 45. Carney RM, Freedland KE. Depression and heart rate variability 
in patients with coronary heart disease. Cleve Clin J Med 2009; 
76(suppl 2):S13–S17. 
 46. Denollet J, Vrints CJ, Conraads VM. Comparing Type D personal-
ity and older age as correlates of tumor necrosis factor- dysregula-
tion in chronic heart failure. Brain Behav Immun 2008; 22:736–743. 
 47. Denollet J, Schiffer AA, Kwaijtaal M, et al. Usefulness of Type 
D personality and kidney dysfunction as predictors of interpatient 
variability in infl ammatory activation in chronic heart failure. Am J 
Cardiol 2009; 103:399–404.
 48. Fischer JC, Kudielka BM, von Känel R, Siegrist J, Thayer JF, 
Fischer JE. Bone-marrow derived progenitor cells are associated 
with psychosocial determinants of health after controlling for clas-
sical biological and behavioral cardiovascular risk factors. Brain 
Behav Immun 2009; 23:419–426.
 49. Van Craenenbroeck EM, Denollet J, Paelinck BP, et al. Circu-
lating CD34+/KDR+ endothelial progenitor cells are reduced in 
chronic heart failure patients as a function of Type D personality. 
Clin Sci 2009; 117:165–172. 
 50. Ladwig K-H, Emeny RT, Gieger C, et al. Single nucleotide poly-
morphism associations with type-D personality in the general popu-
lation: fi ndings from the KORA K-500-substudy. Psychosom Med 
2009; 71:A-28. Abstract 1781.
 51. Kupper N, Boomsma DI, de Geus EJ, Denollet J, Willemsen G. 
Nine-year stability of type D personality: contributions of genes and 
environment. Psychosom Med 2011; 73:75–82. 
 52. Hausteiner C, Klupsch D, Emeny R, Baumert J, Ladwig KH; 
for the KORA Investigators. Clustering of negative affectivity and 
social inhibition in the community: prevalence of type D personality 
as a cardiovascular risk marker. Psychosom Med 2010; 72:163–171. 
 53. Williams L, O’Connor RC, Howard S, et al. Type-D personality 
mechanisms of effect: the role of health-related behavior and social 
support. J Psychosom Res 2008; 64:63–69. 
 54. Polman R, Borkoles E, Nicholls AR. Type D personality, stress, 
and symptoms of burnout: the infl uence of avoidance coping and 
social support. Br J Health Psychol 2010; 15:681–696.
 55. Yu X-N, Chen Z, Zhang J, Liu X. Coping mediates the associa-
tion between Type D personality and perceived health in Chinese 
patients with coronary heart disease. Int J Behav Med 2010; Oct 13 
[Epub ahead of print]. 
 56. Broström A, Strömberg A, Mårtensson J, Ulander M, Harder L, 
CLEVELAND CLINIC JOURNAL OF MEDICINE         VOLUME 78 • SUPPLEMENT 1         AUGUST 2011    S19
DENOLLET AND CONRAADS
Svanborg E. Association of Type D personality to perceived side 
effects and adherence in CPAP-treated patients with OSAS. J Sleep 
Res 2007; 16:439–447. 
 57. Williams L, O’Connor RC, Grubb N, O’Carroll R. Type D per-
sonality predicts poor medication adherence in myocardial infarc-
tion patients [published online ahead of print March 3, 2011]. 
Psychol Health. PMID: 21391133. 
 58. Schiffer AA, Denollet J, Widdershoven JW, Hendriks EH, Smith 
OR. Failure to consult for symptoms of heart failure in patients with 
a type-D personality. Heart 2007; 93:814–818. 
 59. Michal M, Wiltink J, Till Y, et al. Type D personality and deperson-
alization are associated with suicidal ideation in the German general 
population aged 35–74: results from the Gutenberg Heart Study. J 
Affect Disord 2010; 125:227–233. 
 60. Pozuelo L, Panko M, Ching B, et al. Prevalence of anxiety and 
type-D personality in an outpatient ICD clinic. Circulation 2009; 
120:S493–S494. Abstract 1385.
 61. American Psychiatric Association. Diagnostic and Statistical 
Manual of Mental Disorders. Fourth Edition. Washington, DC: 
American Psychiatric Association, 2000. 
 62. Tulloch H, Pelletier R. Does personality matter after all? Type D 
personality and its implications for cardiovascular prevention and 
rehabilitation. Curr Issues Card Rehab Prevention 2008; 16:2–4.
 63. Blumenthal JA, Wang JT, Babyak M, et al. Enhancing standard 
cardiac rehabilitation with stress management training: background, 
methods, and design for the enhanced study. J Cardiopulm Rehabil 
Prev 2010; 30:77–84. 
 64. Denollet J. Sensitivity of outcome assessment in cardiac rehabilita-
tion. J Consult Clin Psychol 1993; 61:686–695. 
 65. Karlsson MR, Edström-Plüss C, Held C, Henriksson P, Bill-
ing E, Wallén NH. Effects of expanded cardiac rehabilitation on 
psychosocial status in coronary artery disease with focus on type D 
characteristics. J Behav Med 2007; 30:253–261.
 66. Pelle AJ, Erdman RA, van Domburg RT, Spiering M, Kazemier 
M, Pedersen SS. Type D patients report poorer health status prior 
to and after cardiac rehabilitation compared to non-type D patients. 
Ann Behav Med 2008; 36:167–175. 
 67. Denollet J, Brutsaert DL. Enhancing emotional well-being by 
comprehensive rehabilitation in patients with coronary heart dis-
ease. Eur Heart J 1995; 16:1070–1078. 
 68. Denollet J, Brutsaert DL. Reducing emotional distress improves 
prognosis in coronary heart disease: 9-year mortality in a clinical 
trial of rehabilitation. Circulation 2001; 104:2018–2023.
Correspondence: Johan Denollet, PhD, CoRPS, Department of Medical 
Psychology and Neuropsychology, Tilburg University, P.O. Box 90153, 5000 LE 
Tilburg, The Netherlands; denollet@uvt.nl
